FibroBiologics, Inc. research brief
CIK 1958777
Generated Nov. 17, 2026, 4:24 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: HOUSTON Texas. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Oct. 13, 2026 · D · 0001493152-26-046663 · Source evidence
Reported offering amount: 1200000 USD. Reported amount sold: 1200000 USD.
- Sept. 16, 2026 · D · 0001493152-26-042792 · Source evidence
Reported offering amount: 500001 USD. Reported amount sold: 500001 USD.
- June 29, 2026 · D · 0001493152-26-031095 · Source evidence
Reported offering amount: 3000000 USD. Reported amount sold: 3000000 USD.
- Dec. 16, 2025 · D · 0001493152-25-028000 · Source evidence
Reported offering amount: 1725001 USD. Reported amount sold: 1725001 USD.
- Dec. 3, 2025 · D · 0001493152-25-025997 · Source evidence
Reported offering amount: 1500000 USD. Reported amount sold: 1500000 USD.
- Dec. 3, 2025 · D · 0001493152-25-025995 · Source evidence
Reported offering amount: 4000000 USD. Reported amount sold: 4000000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “FibroBiologics, Inc. research brief,” CIK 1958777, retrieved Nov. 17, 2026, 4:24 p.m.. Cite the specific accessions used. No amounts have been summed.